These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14627978)

  • 1. Genetic interactions between Pten and p53 in radiation-induced lymphoma development.
    Mao JH; Wu D; Perez-Losada J; Nagase H; DelRosario R; Balmain A
    Oncogene; 2003 Nov; 22(52):8379-85. PubMed ID: 14627978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hipk2 cooperates with p53 to suppress γ-ray radiation-induced mouse thymic lymphoma.
    Mao JH; Wu D; Kim IJ; Kang HC; Wei G; Climent J; Kumar A; Pelorosso FG; DelRosario R; Huang EJ; Balmain A
    Oncogene; 2012 Mar; 31(9):1176-80. PubMed ID: 21785465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Bcl11b genotypes and gamma-radiation on the development of mouse thymic lymphomas.
    Yoshikai Y; Sato T; Morita S; Kohara Y; Takagi R; Mishima Y; Kominami R
    Biochem Biophys Res Commun; 2008 Aug; 373(2):282-5. PubMed ID: 18558082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo.
    Perez-Losada J; Wu D; DelRosario R; Balmain A; Mao JH
    Oncogene; 2005 Aug; 24(35):5521-4. PubMed ID: 16007185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of a possible epigenetic inactivation mechanism operating on a region of mouse chromosome 19 in gamma-radiation-induced thymic lymphomas.
    Santos J; Herranz M; Fernández M; Vaquero C; López P; Fernández-Piqueras J
    Oncogene; 2001 Apr; 20(17):2186-9. PubMed ID: 11360203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of age at exposure on the inactivating mechanisms and relative contributions of key tumor suppressor genes in radiation-induced mouse T-cell lymphomas.
    Sunaoshi M; Amasaki Y; Hirano-Sakairi S; Blyth BJ; Morioka T; Kaminishi M; Shang Y; Nishimura M; Shimada Y; Tachibana A; Kakinuma S
    Mutat Res; 2015 Sep; 779():58-67. PubMed ID: 26141385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.
    Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF
    Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.
    Suzuki A; de la Pompa JL; Stambolic V; Elia AJ; Sasaki T; del Barco Barrantes I; Ho A; Wakeham A; Itie A; Khoo W; Fukumoto M; Mak TW
    Curr Biol; 1998 Oct; 8(21):1169-78. PubMed ID: 9799734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
    Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
    Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
    Snijders AM; Liu Y; Su L; Huang Y; Mao JH
    Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Findley HW; Jiang R; Woods WG
    Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice.
    Wang H; Douglas W; Lia M; Edelmann W; Kucherlapati R; Podsypanina K; Parsons R; Ellenson LH
    Am J Pathol; 2002 Apr; 160(4):1481-6. PubMed ID: 11943731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN and p53 abnormalities are indicative and predictive factors for endometrial carcinoma.
    Inaba F; Kawamata H; Teramoto T; Fukasawa I; Inaba N; Fujimori T
    Oncol Rep; 2005 Jan; 13(1):17-24. PubMed ID: 15583796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of TP53 and PTEN in gliomatosis cerebri.
    Mawrin C; Kirches E; Schneider-Stock R; Scherlach C; Vorwerk C; Von Deimling A; Van Landeghem F; Meyermann R; Bornemann A; Müller A; Romeike B; Stoltenburg-Didinger G; Wickboldt J; Pilz P; Dietzmann K
    Acta Neuropathol; 2003 Jun; 105(6):529-36. PubMed ID: 12734658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression.
    Ma L; Teruya-Feldstein J; Behrendt N; Chen Z; Noda T; Hino O; Cordon-Cardo C; Pandolfi PP
    Genes Dev; 2005 Aug; 19(15):1779-86. PubMed ID: 16027168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of recombinant chromosomes and low fidelity of transmission of chromosome X DNA markers in gamma-ray-induced lymphomas lacking p53.
    Koide N; Matsumoto Y; Kosugi S; Chou D; Sakai K; Hatakeyama K; Niwa O; Kominami R
    Mol Carcinog; 1999 Jan; 24(1):57-63. PubMed ID: 10029411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN and p53: who will get the upper hand?
    Trotman LC; Pandolfi PP
    Cancer Cell; 2003 Feb; 3(2):97-9. PubMed ID: 12620402
    [No Abstract]   [Full Text] [Related]  

  • 18. Accumulation of aberrant Y chromosomes in gamma-ray-induced thymic lymphomas lacking p53.
    Chou D; Matsuki J; Saitou Y; Kosugi SI; Shinbo T; Gejyo F; Niwa O; Kominami R
    Mol Carcinog; 1999 Nov; 26(3):157-62. PubMed ID: 10559790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas.
    Hoogervorst EM; Bruins W; Zwart E; van Oostrom CT; van den Aardweg GJ; Beems RB; van den Berg J; Jacks T; van Steeg H; de Vries A
    Cancer Res; 2005 May; 65(9):3610-6. PubMed ID: 15867355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional evaluation of p53 and PTEN gene mutations in gliomas.
    Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C
    Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.